48 results on '"Ambikan, Anoop T"'
Search Results
2. SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model
3. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
4. Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
5. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
6. Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
7. Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children
8. Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
9. Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection
10. Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children
11. Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection
12. Multiplexed next-generation sequencing and de novo assembly to obtain near full-length HIV-1 genome from plasma virus
13. Differential Immunometabolism and Tissue Responses to Delta and Omicron SARS-CoV-2 Variants in Golden Syrian Hamster Models
14. Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
15. Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
16. Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
17. Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
18. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
19. Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
20. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
21. Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist
22. Metabolic perturbation associated with COVID-19 disease severity and SARS-CoV-2 replication
23. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
24. Implications of central carbon metabolism in SARS-CoV-2 replication and disease severity
25. Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
26. Multiomics Personalized Network Analyses Highlight Progressive Immune Disruption of Central Metabolism Associated with COVID-19 Severity
27. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
28. Integrative Proteo-Transcriptomic and Immunophenotyping Signatures of HIV-1 Elite Control Phenotype: A Cross-Talk Between Glycolysis and HIF Signaling
29. Metabolic reprogramming and host-immune response against Crimean-Congo Hemorrhagic Fever Viruses
30. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals.
31. Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
32. Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
33. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
34. Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
35. Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
36. Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy
37. MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
38. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
39. Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
40. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteotranscriptomics of SARS-CoV-2 infected cells.
41. Systemic inflammation and risk of age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy
42. Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
43. Multi-omics Insights Into Host-viral Response and Pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for Novel Therapeutic Target.
44. SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model.
45. Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children.
46. Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications.
47. Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling.
48. MiDRM pol : A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.